ESC 365 - Welcome and introduction.

ESC Premium Access

Welcome and introduction.

Session: Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios

Topic: Venous Thromboembolism

Speaker: Professor S. Konstantinides (Mainz, DE)

Sponsored by Bayer AG

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Stavros V Konstantinides

University Medical Center of Mainz, Mainz (Germany)

40 presentations

3 followers

6 more presentations in this session

Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.

Speaker: Professor S. Konstantinides (Mainz, DE)

Q&A.

Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.

Speaker: Professor J. Weitz (Hamilton, CA)

Q&A.

Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?

Speaker: Professor A. Khorana

Access the full session

Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios

Speakers: Professor S. Konstantinides, Professor S. Konstantinides, Professor J. Weitz, Professor A. Khorana

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

Open Access

Introduction: Digital health and CVD prevention - natural partners.

28 August 2021

ESC Premium Access

Severe biventricular myocardial involvement in Systemic sclerosis.

27 August 2021

ESC Premium Access

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

27 August 2021

ESC 365 is supported by